Skip to main content

Table 2 Clinicopathological features of the 11 PTBC patients

From: Breast cancer after kidney transplantation: a single institution review

Patient

Age

Duration to diagnosis (months)

Procedure

Stage

Positivity of hormone receptor

Type of chemotherapya

Recurrence

Status

Follow-up duration (months)

1

42

42

SM with SLNB

I

+

-

-

Alive

127

2

49

6

MRM

I

+

-

-

Alive

119

3

28

127

MRM

III

-

CAF(Ă—6)

Bone, lung

Dead

95

4

24

134

Excision biopsy

Unknown

-

-

-

Alive

146

5

40

177

SM with SLNB

I

-

-

-

Alive

101

6

43

181

MRM

III

-

CMF(Ă—6) + AT(Ă—4)

Bone, lung, liver

Dead

30

7

35

89

MRM

III

-

AC(Ă—4) + T(Ă—4)

-

Alive

49

8

28

354

SM with SLNB

II

+

AC(Ă—4)

-

Alive

8

9

29

176

WE with SLNB

I

+

-

-

Alive

37

10

29

208

SM with SLNB

I

-

-

-

Alive

28

11

38

8

MRM

III

+

AC(Ă—4)

-

Alive

17

  1. aC: cyclophosphamide, M: methotrexate, F: 5-fluorouracil, A: adriamycin, T: taxotere.
  2. MRM: modified radical mastectomy; SLNB: sentinel lymph node biopsy;SM: simple mastectomy;WE: wide excision.